Drug intelligence / Profile preview

Enteroflor

Development stage: Unknown
Lead developer: Laboratoires Elerté
Modality: Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Enteroflor is a probiotic dietary supplement developed by Laboratoires Élerté to support gastrointestinal health and maintain the balance of the intestinal microbiota. The formulation typically combines the probiotic yeast *Saccharomyces boulardii* with several strains of lactic acid bacteria, including *Lactobacillus acidophilus*, *Lactobacillus rhamnosus*, and *Bifidobacterium longum*. These microorganisms work synergistically to colonize the gut, inhibit the growth of pathogenic bacteria through competitive exclusion, and enhance the intestinal barrier function. It is commonly used to prevent or treat diarrhea, including antibiotic-associated diarrhea, and to alleviate symptoms of dysbiosis by restoring a healthy microbial environment in the digestive tract.

Brand names: Enteroflor

Beyond the preview

Go deeper on Enteroflor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteroflor.

Explore the full profile